Predicine, Inc. Sustainability Profile
Predicine, Inc., a leading player in the precision medicine industry, is headquartered in the United States, with significant operations across key regions globally. Founded in 2015, the company has rapidly established itself as a pioneer in genomic profiling and liquid biopsy technologies, focusing on oncology and other critical health areas. Predicine's core offerings include advanced genomic testing services and innovative biomarker solutions that enable personalised treatment strategies for cancer patients. What sets Predicine apart is its commitment to integrating comprehensive genomic data with clinical insights, enhancing the accuracy of diagnostics and therapeutic decisions. With a strong market position, Predicine has achieved notable milestones, including collaborations with major pharmaceutical companies and contributions to groundbreaking research in cancer treatment. The company continues to drive advancements in precision medicine, making significant strides in improving patient outcomes.
DitchCarbon Score
How does Predicine, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Predicine, Inc.'s score of 18 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Predicine, Inc.'s reported carbon emissions
Predicine, Inc., headquartered in the US, currently does not have any reported carbon emissions data for the latest year. As such, there are no specific figures available for Scope 1, Scope 2, or Scope 3 emissions. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, nor does it participate in recognised frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Without emissions data or reduction initiatives, it is unclear how Predicine, Inc. is addressing its carbon footprint or contributing to climate action within its industry. The absence of specific commitments or targets suggests a potential area for development in their sustainability strategy.
How Carbon Intensive is Predicine, Inc.'s Industry?
How Carbon Intensive is Predicine, Inc.'s Location?
Predicine, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Predicine, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
